TRIPS COVID-19 Intellectual Property Waiver: Response to Reported Compromise Posted on 15 June 2022 TRIPS COVID-19 Intellectual Property Waiver: Response to Reported Compromise Posted on 15 June 2022
More Accessible COVID-19 Technology on the Horizon: The National Institute of Health Licenses its COVID-19 Tech Patents to the WHO and the Medicines Patent Pool Posted on 10 June 2022 More Accessible COVID-19 Technology on the Horizon: The National Institute of Health Licenses its COVID-19 Tech Patents to the WHO and the Medicines Patent Pool Posted on 10 June 2022
War and Pandemic: Collateral Damage on IP Rights Posted on 9 June 2022 War and Pandemic: Collateral Damage on IP Rights Posted on 9 June 2022
Australia’s Reversal of its DABUS decision on AI-Generated Inventions: How Does this Impact an Imminent Canadian Discussion on AI Inventorship? Posted on 2 June 2022 Australia’s Reversal of its DABUS decision on AI-Generated Inventions: How Does this Impact an Imminent Canadian Discussion on AI Inventorship? Posted on 2 June 2022
Google’s dialogue in the conversation of improving the US Patent System Posted on 31 May 2022 Google’s dialogue in the conversation of improving the US Patent System Posted on 31 May 2022
Peloton, Lululemon and Nike Patent Infringement Lawsuits: Practical Intellectual Property Considerations Posted on 30 May 2022 Peloton, Lululemon and Nike Patent Infringement Lawsuits: Practical Intellectual Property Considerations Posted on 30 May 2022
Where’s the Beef: Patent Battle Over Artificial Meats Posted on 16 May 2022 Where’s the Beef: Patent Battle Over Artificial Meats Posted on 16 May 2022
Russia responds to imposed sanctions by legalizing intellectual property theft against all countries in the European Union, and 23 others Posted on 13 May 2022 Russia responds to imposed sanctions by legalizing intellectual property theft against all countries in the European Union, and 23 others Posted on 13 May 2022
Nobel Prize Winners of CRISPR/Cas9 Lose Decade Long Patent Battle to the Broad Institute of MIT and Harvard Posted on 25 April 2022 Nobel Prize Winners of CRISPR/Cas9 Lose Decade Long Patent Battle to the Broad Institute of MIT and Harvard Posted on 25 April 2022
Gilead and ViiV Healthcare Settle Global Patent Dispute for Over $1B USD Posted on 22 April 2022 Gilead and ViiV Healthcare Settle Global Patent Dispute for Over $1B USD Posted on 22 April 2022